ANTINEOVASCULARISATION AGENTS
- aflibercept (AFLIVU, PAVBLU, EYLEA HD, EYLEA, EYDENZELT, YESAFILI, ENZEEVU)
- brolucizumab (BEOVU)
- faricimab (VABYSMO)
- ranibizumab (MELVIZO, RANOPTO, LUCENTIS)
- verteporfin (VISUDYNE)
Using Health Canada Drug Database
updated on 11Apr2026.